Day One Reports First Quarter 2024 Financial Results and Corporate Progress
May 06, 2024 16:30 ET
|
Day One Biopharmaceuticals, Inc.
OJEMDA™ (tovorafenib) launch underway following U.S. FDA accelerated approval for relapsed or refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) First prescriptions received in the U.S. ...
KULR Technology Group Lends Battery Production Infrastructure for Rapid Support of NASA's R5 Program
May 02, 2024 08:30 ET
|
KULR Technology Group, Inc.
KULR’s New Texas Battery Center of Excellence Facility Demonstrates Fast Turn-Around Time for Customers
OJEMDA™ (tovorafenib) Now Available from Onco360 for the Treatment of Patients Six Months of Age and Older with Relapsed or Refractory Pediatric Low-Grade Glioma (LGG) Harboring a BRAF Fusion or Rearrangement, or BRAF V600 Mutation
April 29, 2024 07:30 ET
|
Onco360 Oncology Pharmacy
LOUISVILLE, Ky., April 29, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Day One Biopharmaceuticals for OJEMDA™...
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
April 23, 2024 15:56 ET
|
Day One Biopharmaceuticals, Inc.
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Co
Compass Diversified-Backed The Honey Pot Co. Strengthens Its Board With The Appointment of Three New Directors
April 18, 2024 09:00 ET
|
Compass Diversified Holdings
WESTPORT, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- The Honey Pot Company, LLC (“The Honey Pot Co.” or “the Company”), a leading “better-for-you” feminine care brand, together with its partner,...
FireFly Neuroscience Announces Healthcare Science and AI Industry Leader David DeCaprio to Join Board of Directors
April 17, 2024 08:30 ET
|
WaveDancer, Inc.
FAIRFAX, Va. and TORONTO, April 17, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”), a pioneering AI company developing innovative neuroscientific solutions to...
AMD Expands Commercial AI PC Portfolio to Deliver Leadership Performance Across Professional Mobile and Desktop Systems
April 16, 2024 09:00 ET
|
Advanced Micro Devices, Inc.
— AMD Ryzen™ PRO 8040 Series and AMD Ryzen™ PRO 8000 Series provide businesses with the most advanced x86 processors1 for AI PCs — SANTA CLARA, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- Today, AMD...
Decatur Children’s Book Festival Debuts May 3-5
April 09, 2024 14:09 ET
|
Decatur Children's Book Festival
Decatur Children’s Book Festival debuts May 3-5 in Decatur, Georgia.
Hippocratic AI Raises $53 Million Series A at a $500 Million Valuation
March 18, 2024 18:05 ET
|
Hippocratic AI
PALO ALTO, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Hippocratic AI, the company building the first safety-focused Large Language Model (LLM) for healthcare, today announced the close of a $53...
WaveDancer and Firefly Neuroscience, an AI-Driven Brain Health Company, Each Receive Respective Stockholder Approvals for Merger
March 18, 2024 09:10 ET
|
WaveDancer, Inc.
FAIRFAX, Va., March 18, 2024 (GLOBE NEWSWIRE) -- WaveDancer, Inc. (“WaveDancer”) (Nasdaq: WAVD) and Firefly Neuroscience, Inc. (“Firefly”) an AI-driven brain health company, each received the...